Circular RNA 0016788 Displays as a Biomarker for Tumor Progression and Poor Prognosis in Surgical Hepatocellular Carcinoma Patients

Journal of Clinical Laboratory Analysis - United States
doi 10.1002/jcla.23300
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Circular RNA Hsa_circ_0078602 May Have Potential as a Prognostic Biomarker for Patients With Hepatocellular Carcinoma

Oncology Letters
Cancer ResearchOncology
2018English

Neutrophils: Driving Progression and Poor Prognosis in Hepatocellular Carcinoma?

British Journal of Cancer
Cancer ResearchOncology
2017English

Mitofusin-2 Acts as Biomarker for Predicting Poor Prognosis in Hepatitis B Virus Related Hepatocellular Carcinoma

Infectious Agents and Cancer
Cancer ResearchEpidemiologyOncologyInfectious Diseases
2018English

Serum Long Noncoding RNA LRB1 as a Potential Biomarker for Predicting the Diagnosis and Prognosis of Human Hepatocellular Carcinoma

Oncology Letters
Cancer ResearchOncology
2018English

Low Levels of Tumor Suppressor Candidate 3 Predict Poor Prognosis of Patients With Hepatocellular Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2018English

Exosomal miR-665 as a Novel Minimally Invasive Biomarker for Hepatocellular Carcinoma Diagnosis and Prognosis

Oncotarget
Oncology
2017English

Low Mir-372 Expression Correlates With Poor Prognosis and Tumor Metastasis in Hepatocellular Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

Upregulation of NETO2 Expression Correlates With Tumor Progression and Poor Prognosis in Colorectal Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

Ferroportin in the Progression and Prognosis of Hepatocellular Carcinoma

European Journal of Medical Research
Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy